Codes / ICD10CM / T50.Z94D

T50.Z94D Poisoning by other vaccines and biological substances, undetermined, subsequent encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by other vaccines and biological substances, undetermined, subsequent encounter

Summary

This condition represents a subsequent encounter for poisoning by vaccines or other biological substances where the intent (accidental, intentional, or undetermined) is unspecified. It applies to encounters occurring after the initial treatment phase, focusing on ongoing management or complications related to the exposure.

Causes

Exposure may result from ingestion, injection, or contact with vaccines or biological substances. The specific agent and circumstances (e.g., therapeutic error, accidental exposure, or unknown intent) influence the clinical scenario, though the intent remains undetermined in this code.

Risk Factors

  • Prior exposure to vaccines or biological substances
  • Underlying conditions affecting response to biological agents
  • Incomplete documentation of exposure circumstances
  • History of adverse reactions to similar substances

Symptoms

  • Persistent or recurrent adverse effects (e.g., fever, fatigue, localized reactions)
  • Systemic symptoms (e.g., nausea, dizziness, allergic responses)
  • Complications from initial exposure (e.g., infection, organ dysfunction)
  • Variable presentation based on the biological agent involved

Diagnosis

Diagnosis relies on patient history of prior exposure, clinical evaluation for residual or new symptoms, and review of initial encounter details. Laboratory tests may assess ongoing effects, while documentation of the encounter timing (subsequent) is critical for coding.

Treatment Options

  • Monitoring for delayed or recurrent symptoms
  • Symptomatic management of persistent effects
  • Referral to specialists if complications arise
  • Follow-up care to address unresolved issues

Prognosis and Follow-Up

Prognosis depends on the severity of the initial exposure and any resulting complications. Follow-up ensures resolution of symptoms, addresses long-term effects, and documents the encounter as a subsequent episode for continuity of care.

Complications

  • Persistent allergic reactions or sensitization
  • Organ dysfunction from toxic effects
  • Infection or inflammation at exposure sites
  • Psychological impact if intent was unclear

Lifestyle & Prevention

  • Avoid re-exposure to the causative agent
  • Maintain awareness of vaccine or biological substance handling
  • Follow prescribed post-exposure protocols
  • Report any new symptoms promptly

When to Seek Professional Help

Seek care if new or worsening symptoms occur, such as severe allergic reactions, difficulty breathing, or signs of infection. Ongoing monitoring by a healthcare provider is recommended for unresolved issues.

Tips for Medical Coders

Document the encounter as a subsequent episode, confirming the timing relative to the initial poisoning event. Ensure clinical notes specify the undetermined intent and reference the biological substance involved. Code T50.Z94D is appropriate for encounters occurring after the acute phase of treatment.

Book a walkthrough

T50.Z94D policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.